BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15611232)

  • 1. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells.
    Dikopoulos N; Bertoletti A; Kröger A; Hauser H; Schirmbeck R; Reimann J
    J Immunol; 2005 Jan; 174(1):99-109. PubMed ID: 15611232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.
    Bochtler P; Kröger A; Schirmbeck R; Reimann J
    J Immunol; 2008 Aug; 181(3):1633-43. PubMed ID: 18641299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.
    Dubois A; Deruytter N; Adams B; Kanda A; Delbauve S; Fleury S; Torres D; François A; Pétein M; Goldman M; Dombrowicz D; Flamand V
    J Immunol; 2010 Jul; 185(2):884-91. PubMed ID: 20562264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis.
    Ismail N; Soong L; McBride JW; Valbuena G; Olano JP; Feng HM; Walker DH
    J Immunol; 2004 Feb; 172(3):1786-800. PubMed ID: 14734762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody.
    Noble A; Leggat JA; Inderberg EM
    Immunology; 2003 Aug; 109(4):476-86. PubMed ID: 12871213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion.
    Frenz T; Waibler Z; Hofmann J; Hamdorf M; Lantermann M; Reizis B; Tovey MG; Aichele P; Sutter G; Kalinke U
    Eur J Immunol; 2010 Oct; 40(10):2769-77. PubMed ID: 20821729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis.
    Hou L; Jie Z; Liang Y; Desai M; Soong L; Sun J
    Cell Mol Immunol; 2015 Mar; 12(2):213-21. PubMed ID: 25027969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective role for the p55 Kd TNF-alpha receptor in immune unresponsiveness induced by an acute viral encephalitis.
    Camelo S; Lafage M; Galelli A; Lafon M
    J Neuroimmunol; 2001 Feb; 113(1):95-108. PubMed ID: 11137581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
    Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
    J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene.
    Persky ME; Murphy KM; Farrar JD
    J Immunol; 2005 Jan; 174(1):294-301. PubMed ID: 15611252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
    Foucras G; Coudert JD; Coureau C; Guéry JC
    J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+Foxp3+ regulatory T cells contribute in liver fibrosis improvement with interferon alpha.
    Feng L; Kang H; Liu LN; Cao YM
    Inflammation; 2013 Dec; 36(6):1374-82. PubMed ID: 23813328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
    Wang X; Mosmann T
    J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of regulatory CD8+ CD25+ T cells after neonatal alloimmunization.
    Adams B; Dubois A; Delbauve S; Debock I; Lhommé F; Goldman M; Flamand V
    Clin Exp Immunol; 2011 Mar; 163(3):354-61. PubMed ID: 21175595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
    Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
    J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production.
    Waidmann M; Allemand Y; Lehmann J; di Genaro S; Bücheler N; Hamann A; Autenrieth IB
    Gut; 2002 Feb; 50(2):170-9. PubMed ID: 11788555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses.
    Kang SS; Allen PM
    J Immunol; 2005 May; 174(9):5382-9. PubMed ID: 15843536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.